Seer, Inc. (SEER) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US81578P1066
Seer, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 16.58 m USD |
| Gross profit | 8.47 m USD |
| Operating income | -77.99 m USD |
| EBIT | -84.92 m USD |
| Net income | -73.60 m USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Seer, Inc.
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
More stocks
- Uni Charm Indonesia PT (UCID.JK)
- CHA Vaccine Institute Co. Ltd. (261780.KQ)
- KP Tissue Inc (KPT.TO)
- PCC Exol SA (PCX.WA)
- Agabang&Company (013990.KQ)
- Ying Han Technology Co Ltd (4562.TW)
- Vivani Medical, Inc. (VANI)
- CS BEARING Co.Ltd (297090.KQ)
- QumulusAI, Inc. Common Stock (QMLS)
- Sand Nisko Capital Bhd (7943.KL)
- Roadzen Inc. (RDZN)
- INITECH Co. Ltd (053350.KQ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.